TWI580964B - 皮膚的壓力蓄積度的評價方法 - Google Patents
皮膚的壓力蓄積度的評價方法 Download PDFInfo
- Publication number
- TWI580964B TWI580964B TW101105615A TW101105615A TWI580964B TW I580964 B TWI580964 B TW I580964B TW 101105615 A TW101105615 A TW 101105615A TW 101105615 A TW101105615 A TW 101105615A TW I580964 B TWI580964 B TW I580964B
- Authority
- TW
- Taiwan
- Prior art keywords
- skin
- hsp27
- stratum corneum
- amount
- expression
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 41
- 238000009825 accumulation Methods 0.000 title claims description 38
- 108010045100 HSP27 Heat-Shock Proteins Proteins 0.000 claims description 126
- 210000003491 skin Anatomy 0.000 claims description 117
- 210000000434 stratum corneum Anatomy 0.000 claims description 96
- 230000014509 gene expression Effects 0.000 claims description 60
- 230000037307 sensitive skin Effects 0.000 claims description 31
- 238000011156 evaluation Methods 0.000 claims description 27
- 230000036074 healthy skin Effects 0.000 claims description 20
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 7
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 7
- 102100039165 Heat shock protein beta-1 Human genes 0.000 claims description 5
- 230000001186 cumulative effect Effects 0.000 claims description 3
- 102000005623 HSP27 Heat-Shock Proteins Human genes 0.000 description 122
- 108090000623 proteins and genes Proteins 0.000 description 49
- 102000004169 proteins and genes Human genes 0.000 description 49
- 238000002474 experimental method Methods 0.000 description 24
- 239000002537 cosmetic Substances 0.000 description 18
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- 230000035882 stress Effects 0.000 description 14
- 238000011002 quantification Methods 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 206010012438 Dermatitis atopic Diseases 0.000 description 10
- 201000008937 atopic dermatitis Diseases 0.000 description 10
- 238000000605 extraction Methods 0.000 description 10
- 238000000265 homogenisation Methods 0.000 description 10
- 238000005259 measurement Methods 0.000 description 10
- 230000005808 skin problem Effects 0.000 description 7
- 230000000638 stimulation Effects 0.000 description 7
- 239000000872 buffer Substances 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 5
- 210000000245 forearm Anatomy 0.000 description 4
- 230000037311 normal skin Effects 0.000 description 4
- 238000002731 protein assay Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 241000283707 Capra Species 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 239000002033 PVDF binder Substances 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 210000001217 buttock Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000011544 gradient gel Substances 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 3
- BBKDWPHJZANJGB-IKJXHCRLSA-N quizalofop-P-tefuryl Chemical compound O=C([C@H](OC=1C=CC(OC=2N=C3C=CC(Cl)=CC3=NC=2)=CC=1)C)OCC1CCCO1 BBKDWPHJZANJGB-IKJXHCRLSA-N 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 238000008157 ELISA kit Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 101001036709 Homo sapiens Heat shock protein beta-1 Proteins 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 102000053548 human HSPB1 Human genes 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000003716 rejuvenation Effects 0.000 description 2
- 238000007788 roughening Methods 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000036572 transepidermal water loss Effects 0.000 description 2
- HLXHCNWEVQNNKA-UHFFFAOYSA-N 5-methoxy-2,3-dihydro-1h-inden-2-amine Chemical compound COC1=CC=C2CC(N)CC2=C1 HLXHCNWEVQNNKA-UHFFFAOYSA-N 0.000 description 1
- 238000000035 BCA protein assay Methods 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 101100339887 Drosophila melanogaster Hsp27 gene Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 101150096895 HSPB1 gene Proteins 0.000 description 1
- 101710100504 Heat shock protein beta-1 Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000001109 Leukocyte L1 Antigen Complex Human genes 0.000 description 1
- 108010069316 Leukocyte L1 Antigen Complex Proteins 0.000 description 1
- 239000012083 RIPA buffer Substances 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000010413 gardening Methods 0.000 description 1
- 230000008799 immune stress Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/443—Evaluating skin constituents, e.g. elastin, melanin, water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/40—Disorders due to exposure to physical agents, e.g. heat disorders, motion sickness, radiation injuries, altitude sickness, decompression illness
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011040355 | 2011-02-25 | ||
| JP2012012033A JP5658696B2 (ja) | 2011-02-25 | 2012-01-24 | 皮膚のストレス蓄積度の評価方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201235662A TW201235662A (en) | 2012-09-01 |
| TWI580964B true TWI580964B (zh) | 2017-05-01 |
Family
ID=46720714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW101105615A TWI580964B (zh) | 2011-02-25 | 2012-02-21 | 皮膚的壓力蓄積度的評價方法 |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP5658696B2 (https=) |
| KR (1) | KR20130140069A (https=) |
| CN (1) | CN103380375A (https=) |
| TW (1) | TWI580964B (https=) |
| WO (1) | WO2012114932A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5731598B2 (ja) * | 2012-11-02 | 2015-06-10 | 株式会社ファンケル | 荒れ肌の評価方法 |
| CN103808940B (zh) * | 2012-11-02 | 2017-06-06 | 株式会社芳珂 | 粗糙肌肤的评价方法 |
| JP5775540B2 (ja) * | 2013-02-22 | 2015-09-09 | 株式会社ファンケル | 皮膚の紫外線照射により負荷される紫外線ストレスの評価方法 |
| JP2015072226A (ja) * | 2013-10-03 | 2015-04-16 | 住友ベークライト株式会社 | 検査方法 |
| JP5977268B2 (ja) * | 2014-01-09 | 2016-08-24 | 株式会社ファンケル | 肌理の評価方法 |
| JP6530646B2 (ja) * | 2015-06-22 | 2019-06-12 | 株式会社ファンケル | 頭皮の圧縮応力の評価方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4469762B2 (ja) * | 2005-07-26 | 2010-05-26 | 株式会社資生堂 | 敏感肌の評価方法及びその評価キット |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60332363D1 (de) * | 2002-10-02 | 2010-06-10 | Univ British Columbia | Oligonucleotide zur behandlung von prostatakrebs und anderen krebserkrankungen |
| WO2007023808A1 (ja) * | 2005-08-23 | 2007-03-01 | Fancl Corporation | 皮膚老化マーカーとその利用技術 |
| JP4954908B2 (ja) * | 2008-01-21 | 2012-06-20 | 株式会社 資生堂 | 角層タンパク質の可溶性タンパク質の量比を指標とした肌質の評価方法 |
-
2012
- 2012-01-24 JP JP2012012033A patent/JP5658696B2/ja active Active
- 2012-02-14 WO PCT/JP2012/053345 patent/WO2012114932A1/ja not_active Ceased
- 2012-02-14 CN CN2012800090971A patent/CN103380375A/zh active Pending
- 2012-02-14 KR KR1020137014928A patent/KR20130140069A/ko not_active Withdrawn
- 2012-02-21 TW TW101105615A patent/TWI580964B/zh not_active IP Right Cessation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4469762B2 (ja) * | 2005-07-26 | 2010-05-26 | 株式会社資生堂 | 敏感肌の評価方法及びその評価キット |
Non-Patent Citations (1)
| Title |
|---|
| JEANMAIRE C, "What is the Most Suitable Strategy for Stress Proteins in Cosmetics?", 網路文獻: http://www.skin-care-forum.basf.com/en/articles/skin/p/what-is-the-most-suitable-strategy-for-stress-proteins-in-cosmetics-/2004/04/13?id=c08eec7d-ec73-49a8-8d4e-2532ed55677c&mode=Detail, 2004/04 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP5658696B2 (ja) | 2015-01-28 |
| KR20130140069A (ko) | 2013-12-23 |
| JP2012189581A (ja) | 2012-10-04 |
| TW201235662A (en) | 2012-09-01 |
| CN103380375A (zh) | 2013-10-30 |
| WO2012114932A1 (ja) | 2012-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI580964B (zh) | 皮膚的壓力蓄積度的評價方法 | |
| JP5065237B2 (ja) | アトピー性皮膚炎の局所病態の非侵襲的評価方法 | |
| JP2012189581A5 (https=) | ||
| Murdan et al. | An assessment of the human nail plate pH | |
| TWI600904B (zh) | 皮膚應激蓄積度的評價方法 | |
| CN104007056B (zh) | 对紫外线损伤的抵抗性的评价方法 | |
| TWI541506B (zh) | 皮膚壓力蓄積的評價方法 | |
| TWI595235B (zh) | 粗糙肌膚的評估方法 | |
| CN103808940B (zh) | 粗糙肌肤的评价方法 | |
| KR101515189B1 (ko) | 인체 피부의 일차자극 평가 기준에 따른 화장품 안전성 평가 방법 | |
| HK1187677A (en) | Method of evaluating degree of skin stress accumulation | |
| Young et al. | 836 Calibration performance of deep neural networks for image classification declines on real-world, versus curated, test sets | |
| Bax et al. | 839 Spirulina stimulates inflammatory cytokine production in dermatomyositis in vitro | |
| Querfeld et al. | 833 No detectable systemic absorption of topically applied 0.02% and 0.04% chlormethine (CL) gel in patients with mycosis-fungoides cutaneous T-cell lymphoma (MF-CTCL) | |
| Miyai et al. | 837 Micro-regional transcriptome reveals local dermal-epidermal intercorrelation in atopic dermatitis | |
| Wongvibulsin et al. | 841 Machine learning (ML) predictive algorithm for childhood-onset chronic pruritic dermatoses (CPD) identifies acrylamide and glycidamide as itch modulators | |
| Zhao et al. | 838 A guideline improves interrater reliability of assessing leukocyte motion in vivo in human skin | |
| Agarwal et al. | LB724 Human epidermal organoids: Establishing a reproducible stratified human epidermal organoid culture system | |
| Kalahasti et al. | LB726 The combination of 0.5% retinol with a naturally derived TRPV 1 antagonist and anti-inflammatory botanical extract helps mitigate retinoid-induced irritation | |
| Kim et al. | LB725 Skin barrier formation by epigenetic regulation of EGR3 | |
| HK1186245A (en) | Analysis method for skin stress accumulation | |
| HK1198451B (en) | Method for evaluating resistance to ultraviolet damage | |
| Krueger et al. | P1601 | |
| Carlavan | 163 Epidermal barrier improvement after Excipial application in atopic xerosis is revealed by non-invasive proteome analysis | |
| KR20130098211A (ko) | 피부의 스트레스 축적량의 측정방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |